I think this is a rare opportunity and wouldn't want to miss a single share. Long term upside unreal. I think folks realize the enormous market and reality of Regenerative care, everyone benefits less drugs more natural process.
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.